文献速递母胎医学产科

全基因组染色体微阵列分析在低风险妊娠中检出高比例拷贝数变异

Universal chromosomal microarray analysis reveals high proportion of copy-number variants in low-risk pregnancies.
PubMed 文献 · Ultrasound Obstet Gynecol · 2021-04-05

低风险组临床显著早发型CNV检出率为1.1%(72/6431),显著低于高风险组的4.9%(65/1326)。低风险组中0.4%为致病/可能致病CNV,0.7%为外显率>10%的易感位点。

要点

  • 超声正常低风险妊娠中临床显著早发型CNV检出率为1.1%。
  • 低风险组致病/可能致病CNV占0.4%,易感位点(外显率>10%)占0.7%。
  • 低风险组检出显著CNV后31.9%终止妊娠,16.7%后续超声发现异常。

核心结论

  • 低风险妊娠中临床显著早发型CMA异常的背景风险低于高风险妊娠,但风险仍不容忽视,应告知所有孕妇。

主要发现

  • 低风险组临床显著早发型CNV检出率为1.1%(72/6431),高风险组为4.9%(65/1326)。
  • 低风险组致病/可能致病CNV占0.4%(27/6431),外显率>10%的易感位点占0.7%(45/6431)。
  • 低风险组检出显著早发型CNV的72例中,31.9%(23/72)终止妊娠,26.4%(19/72)结局数据缺失。
  • 低风险组中16.7%(12/72)在基因检测后妊娠后期才发现超声异常。

临床怎么用

  • 对超声正常的低风险妊娠,应告知CMA可检出约1.1%的临床显著早发型CNV。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To evaluate the yield and utility of the routine use of chromosomal microarray analysis (CMA) for prenatal genetic diagnosis in a large cohort of pregnancies with normal ultrasound (US) at the time of genetic testing, compared with pregnancies with abnormal US findings. METHODS: We reviewed all prenatal CMA results in our center between November 2013 and December 2018. The prevalence of different CMA results in pregnancies with normal US at the time of genetic testing ('low-risk pregnancies'), was compared with that in pregnancies with abnormal US findings ('high-risk pregnancies'). Medical records were searched in order to evaluate subsequent US follow-up and the outcome of pregnancies with a clinically relevant copy-number variant (CNV), i.e. a pathogenic or likely pathogenic CNV or a susceptibility locus for disease with > 10% penetrance, related to early-onset disease in the low-risk group. RESULTS: In a cohort of 6431 low-risk pregnancies that underwent CMA, the prevalence of a clinically significant CNV related to early-onset disease was 1.1% (72/6431), which was significantly lower than the prevalence in high-risk pregnancies (4.9% (65/1326)). Of the low-risk pregnancies, 0.4% (27/6431) had a pathogenic or likely pathogenic CNV, and another 0.7% (45/6431) had a susceptibility locus with more than 10% penetrance. Follow-up of the low-risk pregnancies with a clinically significant early-onset CNV revealed that 31.9% (23/72) were terminated, while outcome data were missing in 26.4% (19/72). In 16.7% (12/72) of low-risk pregnancies, an US abnormality was discovered later on in gestation, after genetic testing had been performed. CONCLUSION: Although the background risk of identifying a clinically significant early-onset abnormal CMA result in pregnancies with a low a-priori risk is lower than that observed in high-risk pregnancies, the risk is substantial and should be conveyed to all pregnant women. © 2020 International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Stern S, Hacohen N, Meiner V, et al. Universal chromosomal microarray analysis reveals high proportion of copy-number variants in low-risk pregnancies. Ultrasound Obstet Gynecol. 2021. PMID: 32202684. doi:10.1002/uog.22026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。